Join us in Seattle in June 2026 for the 3rd annual BioCentury Grand Rounds – U.S., a premier R&D conference designed to unite critical stakeholders at the forefront of translational science. This highly focused event brings together leading VCs, biopharma decision-makers, and academic innovators to collaboratively explore the most significant breakthroughs, bottlenecks, and strategic decisions that are fundamentally shaping the future trajectory of drug development.

The core mission of the Grand Rounds is to provide a dynamic platform for both strategic debate and valuable opportunity discovery. Attendees will gain the chance to unlock transformative business opportunities and engage in meaningful discussions to debate scientific hurdles directly with the innovators who are driving the most significant biopharma advancements. Furthermore, the conference is structured to allow participants to discover cutting-edge science and pioneering academic research that holds significant commercial potential.

Beyond the formal presentations, the event offers structured networking and actionable intelligence. Participants will gain vital industry insights through focused presentations delivered by both emerging biotechs and key academic innovators. Finally, the conference facilitates efficiency by providing a dedicated platform to schedule partnering meetings with top-tier VCs, major pharmaceutical companies, and leading academics, ensuring productive and immediate collaborations.